Roni Tamari

17PUBLICATIONS
121CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)HaematologyGene and molecular therapyTransplantation immunologyRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 15, 2026
Daratumumab therapy for refractory immune cytopenias after allogeneic hematopoietic cell transplantation.

|May 12, 2026
CRISPR-Cas9 CD33-deleted allogeneic hematopoietic cell transplantation with gemtuzumab ozogamicin maintenance in AML: a phase 1/2 trial.

|Apr 10, 2026
Overcoming MEN1-mediated resistance with menin inhibitor switching in KMT2A-rearranged acute myeloid leukemia.

Kuo-Kai Chin, Maher Abdul-Hay, Mihir Shukla

|Oct 23, 2025
Remission of <i>TP53</i>-Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33).

Guenther Koehne, Muhammad U Mushtaq, Lori S Muffly

|Oct 13, 2025
Defining remission following hematopoietic cell transplant for myelofibrosis: an international expert panel consensus.

Rachel B Salit, Elizabeth O Hexner, Nico Gagelmann

|Mar 22, 2025
Optimization of allogeneic hematopoietic cell transplantation for patients with myelofibrosis treated with ruxolitinib: eligibility, best practices, and improving transplant outcomes.

Sarah A Wall, Roni Tamari, Zachariah DeFilipp

Pageof 3

Frequent Collaborators

6 joint publications

Sergio Giralt

4 joint publications

Doris M Ponce

4 joint publications

Miguel-Angel Perales

3 joint publications

Vikas Gupta